{"id":"W2891872117","doi":"10.1186/s12894-018-0387-7","title":"Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials","year":2018,"lang":"en","type":"article","venue":"BMC Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Astellas Pharma; Clovis Oncology; Genomic Health; Amgen; Pfizer; Augmenix; Sanofi","keywords":"Bicalutamide; Medicine; Enzalutamide; Prostate cancer; Oncology; Internal medicine; Prostate-specific antigen; Progression-free survival; Hazard ratio; Urology; Confidence interval; Cancer; Chemotherapy; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001560692,0.0001149376,0.0007103262,0.0002855955,0.00003081277,0.00000959004,0.00006580781,0.00005907808,0.0000874324],"category_scores_gemma":[0.00040677,0.0000558289,0.00006278342,0.0008092609,0.0002623891,0.0000384731,0.00002634869,0.000133506,0.000002240126],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003613273,"about_ca_system_score_gemma":0.000243007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009195847,"about_ca_topic_score_gemma":0.008955731,"domain_scores_codex":[0.9977846,0.0008150665,0.0006258152,0.0002853629,0.0002587985,0.000230354],"domain_scores_gemma":[0.9988148,0.0005719505,0.0001947363,0.0001979202,0.000144654,0.00007596667],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01441066,0.0004434015,0.9780112,0.00003889473,0.0002061762,0.00002104309,0.001986231,0.0000155305,0.00009332241,0.000009516366,0.00005599869,0.004708058],"study_design_scores_gemma":[0.007905573,0.003187961,0.9869439,0.00002407624,0.001001437,9.930269e-7,0.0004556317,0.0001838248,0.0001580905,0.00002509926,0.00005778748,0.00005560924],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970977,0.0001321529,0.00001334001,0.001067438,0.00002695199,0.001464503,0.00008195617,0.00000416498,0.0001117515],"genre_scores_gemma":[0.9990601,0.00002416362,0.0004111402,0.00017173,0.00002793024,0.0001794035,0.00006189658,0.000007671268,0.00005594651],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008932753,"threshold_uncertainty_score":0.4997508,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09198609631662609,"score_gpt":0.4681050233197285,"score_spread":0.3761189270031025,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}